ImmunityBio
•
2026-06-01
Louisville, Kentucky, US
Scientist I, Process Sciences - Analytical Development
Company OverviewImmunityBio, Inc. (NASDAQ: IBRX) is a commercial-stage biotechnology company developing cell and immunotherapy products that are designed to help strengthen each patient's natural immune system, potentially enabling it to outsmart the disease a…
immunitybio
•
2026-06-04
Louisville, US
Scientist I, Process Sciences - Analytical Development
Company Overview ImmunityBio, Inc. (NASDAQ: IBRX) is a commercial-stage biotechnology company developing cell and immunotherapy products that are designed to help strengthen each patient's natural immune system, potentially enabling it to outsmart the disease …